{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:13:21Z","timestamp":1790748801536,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clnesp.2021.02.017","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T14:25:13Z","timestamp":1615127113000},"page":"64-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-8057","authenticated-orcid":false,"given":"Cinzia","family":"Baldessari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8671-9910","authenticated-orcid":false,"given":"Giorgia","family":"Guaitoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Valoriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bonacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Marcheselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Reverberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-3256","authenticated-orcid":false,"given":"Annarita","family":"Pecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5178-3063","authenticated-orcid":false,"given":"Pietro","family":"Torricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7131-3168","authenticated-orcid":false,"given":"Fausto","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2021.02.017_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2014.00379","article-title":"Role of T cells in malnutrition and obesity","volume":"5","author":"Gerriets","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnesp.2021.02.017_bib2","doi-asserted-by":"crossref","first-page":"1648072","DOI":"10.1155\/2019\/1648072","article-title":"Can inflammatory and nutritional serum markers predict chemotherapy outcomes and survival in advanced stage nonsmall cell lung cancer patients?","volume":"2019","author":"Cehreli","year":"2019","journal-title":"BioMed Res Int"},{"issue":"suppl_2","key":"10.1016\/j.clnesp.2021.02.017_bib3","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/annonc\/mdx810","article-title":"Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy","volume":"29","author":"Baracos","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0029665113001286","article-title":"Feeding the immune system","volume":"72","author":"Calder","year":"2013","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2017.04.001","article-title":"Regulatory T cells as suppressors of anti-tumor immunity: role of metabolism","volume":"35","author":"De Rosa","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.clnesp.2021.02.017_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.clnesp.2021.02.017_bib8","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-17-3287","article-title":"The importance of body composition in explaining the overweight paradox in cancer-counterpoint","volume":"78","author":"Caan","year":"2018","journal-title":"Canc Res"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib9","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clnesp.2021.02.017_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2018.12.003","article-title":"Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology?","volume":"196","author":"Hilmi","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.clnesp.2021.02.017_bib11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","article-title":"Inflammation and sarcopenia: a systematic review and meta-analysis","volume":"96","author":"Bano","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.clnesp.2021.02.017_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.exger.2018.06.013","article-title":"Is increased neutrophil lymphocyte ratio remarking the inflammation in sarcopenia?","volume":"110","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"Exp Gerontol"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib14","doi-asserted-by":"crossref","first-page":"E700","DOI":"10.1210\/jc.2011-2387","article-title":"Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia","volume":"97","author":"Burney","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib15","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"issue":"45","key":"10.1016\/j.clnesp.2021.02.017_bib21","doi-asserted-by":"crossref","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ncponc0033","article-title":"Can weight loss at presentation predict patient outcome in lung cancer?","volume":"1","author":"Temel","year":"2004","journal-title":"Nat Clin Pract Oncol"},{"issue":"10","key":"10.1016\/j.clnesp.2021.02.017_bib24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Canc"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0169-5002(03)00077-1","article-title":"A\u00a0prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer","volume":"40","author":"Scott","year":"2003","journal-title":"Lung Canc"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clnu.2015.03.001","article-title":"Diagnostic criteria for malnutrition - an ESPEN consensus statement","volume":"34","author":"Cederholm","year":"2015","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1079\/BJN20041258","article-title":"Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the 'malnutrition universal screening tool' ('MUST') for adults","volume":"92","author":"Stratton","year":"2004","journal-title":"Br J Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0261-5614(03)00098-0","article-title":"ESPEN guidelines for nutrition screening 2002","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib32","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.clnu.2016.07.014","article-title":"The two most popular malnutrition screening tools in the light of the new ESPEN consensus definition of the diagnostic criteria for malnutrition","volume":"36","author":"Poulia","year":"2017","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/annonc\/mdq440","article-title":"Baseline nutritional evaluation in metastatic lung cancer patients: mini Nutritional Assessment versus weight loss history","volume":"22","author":"Gioulbasanis","year":"2011","journal-title":"Ann Oncol"},{"issue":"1 Suppl","key":"10.1016\/j.clnesp.2021.02.017_bib34","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/0899-9007(95)00067-4","article-title":"Definition of standardized nutritional assessment and interventional pathways in oncology","volume":"12","author":"Ottery","year":"1996","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.lungcan.2011.05.009","article-title":"Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis","volume":"74","author":"Gioulbasanis","year":"2011","journal-title":"Lung Canc"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.amjmed.2015.03.032","article-title":"Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review","volume":"128","author":"Lee","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4149\/318_151001N512","article-title":"Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib","volume":"63","author":"Fiala","year":"2016","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib38","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1038\/s41598-019-44653-x","article-title":"Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study","volume":"9","author":"Yang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2021.02.017_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2017.07.003","article-title":"Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: comparative study of normal lung, emphysema, and pulmonary fibrosis","volume":"111","author":"Miura","year":"2017","journal-title":"Lung Canc"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1186\/s12885-017-3814-3","article-title":"Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status","volume":"17","author":"Ikeda","year":"2017","journal-title":"BMC Canc"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2021.02.017_bib42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bone.2017.09.008","article-title":"A\u00a0review of sarcopenia: enhancing awareness of an increasingly prevalent disease","volume":"105","author":"Marty","year":"2017","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jamda.2011.04.014","article-title":"Sarcopenia with limited mobility: an international consensus","volume":"12","author":"Morley","year":"2011","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib48","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib49","first-page":"2075","article-title":"Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer","volume":"24","author":"Go","year":"2016","journal-title":"Support Care Canc"},{"issue":"12","key":"10.1016\/j.clnesp.2021.02.017_bib50","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/JTO.0000000000000690","article-title":"Prognostic significance of CT-determined sarcopenia in patients with small-cell lung cancer","volume":"10","author":"Kim","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169136","article-title":"Prognostic impact of CT-quantified muscle and fat distribution before and after first-line-chemotherapy in lung cancer patients","volume":"12","author":"Nattenm\u00fcller","year":"2017","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.clnesp.2021.02.017_bib52","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Stene","year":"2015","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib54","first-page":"1699","article-title":"Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer","volume":"23","author":"Kimura","year":"2015","journal-title":"Support Care Canc"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2015.07.001","article-title":"Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer","volume":"90","author":"Sj\u00f8blom","year":"2015","journal-title":"Lung Canc"},{"issue":"8","key":"10.1016\/j.clnesp.2021.02.017_bib56","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2015-0058","article-title":"Nutritional status, body surface, and low lean body mass\/body mass index are related to dose reduction and severe gastrointestinal toxicity induced by afatinib in patients with non-small cell lung cancer","volume":"20","author":"Arrieta","year":"2015","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib57","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jcsm.12418","article-title":"Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment","volume":"10","author":"Antoun","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","article-title":"Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method","volume":"37","author":"Heymsfield","year":"1983","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib59","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1152\/jappl.1981.51.3.762","article-title":"Total plasma creatinine: an accurate measure of total striated muscle mass","volume":"51","author":"Schutte","year":"1981","journal-title":"J\u00a0Appl Physiol Respir Environ Exerc Physiol"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib60","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.21037\/jtd.2016.03.62","article-title":"Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients","volume":"8","author":"Thongprayoon","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib61","article-title":"A\u00a0new equation to estimate muscle mass from creatinine and cystatin C","volume":"11","author":"Kim","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.clnesp.2021.02.017_bib62","series-title":"Obesity: preventing and managing the global epidemic","author":"Organization","year":"2000"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrclinonc.2013.120","article-title":"Clinical management of obese patients with cancer","volume":"10","author":"Tao","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"9612","key":"10.1016\/j.clnesp.2021.02.017_bib64","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"7121","key":"10.1016\/j.clnesp.2021.02.017_bib65","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clnesp.2021.02.017_bib66","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","article-title":"Obesity, inflammation, and cancer","volume":"11","author":"Deng","year":"2016","journal-title":"Annu Rev Pathol"},{"issue":"7","key":"10.1016\/j.clnesp.2021.02.017_bib67","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1470-2045(08)70160-8","article-title":"Excess baggage: sarcopenia, obesity, and cancer outcomes","volume":"9","author":"Roubenoff","year":"2008","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib68","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-017-0464-x","article-title":"Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients","volume":"35","author":"Heidelberger","year":"2017","journal-title":"Invest N Drugs"},{"issue":"24","key":"10.1016\/j.clnesp.2021.02.017_bib69","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jnci\/djt310","article-title":"An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma","volume":"105","author":"Hakimi","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.clnesp.2021.02.017_bib70","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-17-0200","article-title":"Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-scans study)","volume":"26","author":"Caan","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clnesp.2021.02.017_bib71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lungcan.2016.11.017","article-title":"Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)","volume":"104","author":"Lam","year":"2017","journal-title":"Lung Canc"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40425-019-0512-5","article-title":"Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition","volume":"7","author":"Naik","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"10","key":"10.1016\/j.clnesp.2021.02.017_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204729","article-title":"Body mass index may predict the response to ipilimumab in metastatic melanoma: an observational multi-centre study","volume":"13","author":"Richtig","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A\u00a0multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1148\/radiology.211.1.r99ap15283","article-title":"Abdominal fat: standardized technique for measurement at CT","volume":"211","author":"Yoshizumi","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.clnesp.2021.02.017_bib78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.lungcan.2019.05.021","article-title":"The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer","volume":"133","author":"Degens","year":"2019","journal-title":"Lung Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib79","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clinimag.2018.05.006","article-title":"Effect of adipose tissue volume on prognosis in patients with non-small cell lung cancer","volume":"50","author":"Lee","year":"2018","journal-title":"Clin Imag"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib80","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1580128","article-title":"Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET\/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab","volume":"8","author":"Popinat","year":"2019","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib81","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/bjc.2017.149","article-title":"Subcutaneous adiposity is an independent predictor of mortality in cancer patients","volume":"117","author":"Ebadi","year":"2017","journal-title":"Br J Canc"},{"issue":"6917","key":"10.1016\/j.clnesp.2021.02.017_bib82","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2021.02.017_bib83","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114512005119","article-title":"A\u00a0consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies","volume":"109","author":"Calder","year":"2013","journal-title":"Br J Nutr"},{"issue":"11","key":"10.1016\/j.clnesp.2021.02.017_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080240","article-title":"Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer","volume":"8","author":"Koma","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib85","first-page":"213","article-title":"Prognostic value of red blood cell distribution width in non-small cell lung cancer treated with anti-programmed cell death-1 antibody","volume":"33","author":"Kiriu","year":"2019","journal-title":"In\u00a0Vivo"},{"issue":"7","key":"10.1016\/j.clnesp.2021.02.017_bib86","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s10147-019-01417-x","article-title":"A\u00a0prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width","volume":"24","author":"Bozkaya","year":"2019","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib87","first-page":"153","article-title":"Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients","volume":"20","author":"Kos","year":"2016","journal-title":"Contemp Oncol (Pozn)"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib88","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000531","article-title":"Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors","volume":"4","author":"Iivanainen","year":"2019","journal-title":"ESMO Open"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib89","first-page":"3098","article-title":"Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis","volume":"8","author":"Peng","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"10.1016\/j.clnesp.2021.02.017_bib90","doi-asserted-by":"crossref","first-page":"524","DOI":"10.6061\/clinics\/2015(07)10","article-title":"Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis","volume":"70","author":"Yin","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.clnesp.2021.02.017_bib91","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/srep12493","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis","volume":"5","author":"Gu","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib92","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3892\/mco.2017.1342","article-title":"Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: a meta-analysis of 7,219 patients","volume":"7","author":"Yu","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.clnesp.2021.02.017_bib93","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2019.02.009","article-title":"Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1\/PD-L1 inhibitors","volume":"130","author":"Jiang","year":"2019","journal-title":"Lung Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib94","doi-asserted-by":"crossref","first-page":"34823","DOI":"10.1038\/srep34823","article-title":"The prognostic value of PLR in lung cancer, a meta-analysis based on results from a large consecutive cohort","volume":"6","author":"Ding","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2021.02.017_bib95","doi-asserted-by":"crossref","first-page":"105957","DOI":"10.1016\/j.intimp.2019.105957","article-title":"Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"77","author":"Xu","year":"2019","journal-title":"Int Immunopharm"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/wjon1097w","article-title":"Comparison of inflammation-based prognostic scores in patients undergoing curative resection for non-small cell lung cancer","volume":"9","author":"Tomita","year":"2018","journal-title":"World J Oncol"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib97","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/icvts\/ivx337","article-title":"Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study","volume":"26","author":"Shoji","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib98","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ajco.13055","article-title":"Effect of C-reactive protein\/albumin ratio on prognosis in advanced non-small-cell lung cancer","volume":"14","author":"Ni","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"issue":"17","key":"10.1016\/j.clnesp.2021.02.017_bib99","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","article-title":"A\u00a0comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study","volume":"47","author":"Proctor","year":"2011","journal-title":"Eur J Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2019.08.006","article-title":"Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors","volume":"136","author":"Shoji","year":"2019","journal-title":"Lung Canc"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091304","article-title":"The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: a systematic review","volume":"11","author":"Abbass","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clnesp.2021.02.017_bib102","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bone.2018.01.004","article-title":"Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers","volume":"108","author":"Chambard","year":"2018","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.clnesp.2021.02.017_bib103","first-page":"4495","article-title":"Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value","volume":"24","author":"Srdic","year":"2016","journal-title":"Support Care Canc"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib104","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.lungcan.2015.03.020","article-title":"Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factors","volume":"88","author":"Simmons","year":"2015","journal-title":"Lung Canc"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib105","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","article-title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer","volume":"89","author":"Forrest","year":"2003","journal-title":"Br J Canc"},{"issue":"10","key":"10.1016\/j.clnesp.2021.02.017_bib106","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/sj.bjc.6602591","article-title":"A\u00a0prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer","volume":"92","author":"Forrest","year":"2005","journal-title":"Br J Canc"},{"issue":"8","key":"10.1016\/j.clnesp.2021.02.017_bib107","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00384-006-0259-6","article-title":"Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer","volume":"22","author":"McMillan","year":"2007","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib108","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br J Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib109","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.lungcan.2017.04.015","article-title":"Corrigendum to \"Prognosis in advanced lung cancer - a prospective study examining key clinicopathological factors\" [Lung Cancer 88 (2015) 304-309]","volume":"108","author":"Simmons","year":"2017","journal-title":"Lung Canc"},{"issue":"12","key":"10.1016\/j.clnesp.2021.02.017_bib110","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/cncr.28018","article-title":"Optimization of the systemic inflammation-based glasgow prognostic score: a glasgow inflammation outcome study","volume":"119","author":"Proctor","year":"2013","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116206","article-title":"Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study","volume":"10","author":"Proctor","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.clnesp.2021.02.017_bib112","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1038\/srep10481","article-title":"Ratio of C-reactive protein\/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.clnesp.2021.02.017_bib113","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00595-016-1448-8","article-title":"Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients","volume":"47","author":"Miyazaki","year":"2017","journal-title":"Surg Today"},{"issue":"19","key":"10.1016\/j.clnesp.2021.02.017_bib114","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006848","article-title":"Prognostic impact of C-reactive protein\/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy","volume":"96","author":"Koh","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib115","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.18632\/oncotarget.13053","article-title":"The C-reactive protein\/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clnesp.2021.02.017_bib116","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review","volume":"13","author":"Jafri","year":"2013","journal-title":"BMC Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib117","first-page":"976","article-title":"Advanced Lung Cancer Inflammation index: a prognostic score in patients with metastatic non-small cell lung cancer","author":"Bacha","year":"2017","journal-title":"Tunis Med"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib118","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/crj.12768","article-title":"Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?","volume":"12","author":"Ozyurek","year":"2018","journal-title":"Clin Res J"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib119","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cam4.1234","article-title":"Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer","volume":"7","author":"Shiroyama","year":"2018","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5761\/atcs.oa.18-00158","article-title":"Advanced lung cancer inflammation index predicts outcomes of patients with pathological stage IA lung adenocarcinoma following surgical resection","volume":"25","author":"Kobayashi","year":"2019","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"10","key":"10.1016\/j.clnesp.2021.02.017_bib121","article-title":"Prognostic significance of modified advanced lung cancer inflammation index (ALI) in patients with small cell lung cancer_ comparison with original ALI","volume":"11","author":"Kim","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib122","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamaoncol.2017.4771","article-title":"Association of the lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer","volume":"4","author":"Mezquita","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib123","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0885-3924(02)00508-0","article-title":"The cancer anorexia-cachexia syndrome: a survey of the Prognostic Inflammatory and Nutritional Index (PINI) in advanced disease","volume":"24","author":"Nelson","year":"2002","journal-title":"J\u00a0Pain Symptom Manag"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib124","first-page":"1001","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"8","key":"10.1016\/j.clnesp.2021.02.017_bib125","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1245\/s10434-013-2926-5","article-title":"The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage","volume":"20","author":"Migita","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib126","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.7314\/APJCP.2015.16.9.3997","article-title":"Assessment of prognostic value of \"neutrophil to lymphocyte ratio\" and \"prognostic nutritional index\" as a sytemic inflammatory marker in non-small cell lung cancer","volume":"16","author":"Kos","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136897","article-title":"The significance of the prognostic nutritional index in patients with completely resected non-small cell lung cancer","volume":"10","author":"Mori","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/01635581.2015.1032430","article-title":"Evaluation of prognostic nutritional index in patients undergoing radical surgery with nonsmall cell lung cancer","volume":"67","author":"Qiu","year":"2015","journal-title":"Nutr Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12957-015-0710-7","article-title":"Preoperative neutrophil\/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer","volume":"13","author":"Shimizu","year":"2015","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib130","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3904\/kjim.2015.062","article-title":"Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations","volume":"31","author":"Park","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147226","article-title":"Low prognostic nutritional index correlates with worse survival in patients with advanced NSCLC following EGFR-TKIs","volume":"11","author":"Sheng","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.clnesp.2021.02.017_bib132","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lungcan.2016.05.010","article-title":"Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer","volume":"98","author":"Shoji","year":"2016","journal-title":"Lung Canc"},{"key":"10.1016\/j.clnesp.2021.02.017_bib133","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2147\/OTT.S138854","article-title":"Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer","volume":"10","author":"Chen","year":"2017","journal-title":"OncoTargets Ther"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib134","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.athoracsur.2017.01.085","article-title":"Clinical significance of prognostic nutritional index after surgical treatment in lung cancer","volume":"104","author":"Okada","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12967-017-1326-1","article-title":"Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer","volume":"15","author":"Tong","year":"2017","journal-title":"J\u00a0Transl Med"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib136","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jjco\/hyy014","article-title":"Preoperative prognostic nutritional index as a predictor of outcomes in elderly patients after surgery for lung cancer","volume":"48","author":"Watanabe","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clnesp.2021.02.017_bib137","first-page":"2273","article-title":"Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?","volume":"28","author":"Bozkaya","year":"2019","journal-title":"Support Care Canc"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib138","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4149\/neo_2019_190125N76","article-title":"Prognostic impact of prognostic nutritional index in advanced (stage IIIB\/IV) non-small cell lung cancer patients","volume":"66","author":"Li","year":"2019","journal-title":"Neoplasma"},{"issue":"7","key":"10.1016\/j.clnesp.2021.02.017_bib139","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/01635581.2019.1598564","article-title":"Can nutritional status predict overall survival in patients with advanced non-small cell lung cancer?","volume":"71","author":"Seo","year":"2019","journal-title":"Nutr Canc"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3747\/co.v17i4.567","article-title":"The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer","volume":"17","author":"Kasymjanova","year":"2010","journal-title":"Curr Oncol"},{"issue":"23","key":"10.1016\/j.clnesp.2021.02.017_bib141","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.clnesp.2021.02.017_bib142","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cca.2018.05.059","article-title":"Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer","volume":"484","author":"Gao","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"25","key":"10.1016\/j.clnesp.2021.02.017_bib143","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2217\/fon-2018-0285","article-title":"Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer","volume":"14","author":"Guo","year":"2018","journal-title":"Future Oncol"},{"issue":"33","key":"10.1016\/j.clnesp.2021.02.017_bib144","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016875","article-title":"High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs","volume":"98","author":"Deng","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1759-7714.12995","article-title":"Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer","volume":"10","author":"Guo","year":"2019","journal-title":"Thorac Cancer"},{"issue":"6","key":"10.1016\/j.clnesp.2021.02.017_bib146","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41435-018-0050-z","article-title":"Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations","volume":"20","author":"Li","year":"2019","journal-title":"Gene Immun"},{"issue":"8","key":"10.1016\/j.clnesp.2021.02.017_bib147","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22964","article-title":"Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab","volume":"33","author":"Liu","year":"2019","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib148","first-page":"90","article-title":"Predicting 5-year progression and survival outcomes for early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy: development and validation of robust prognostic nomograms","volume":"106","author":"Kang","year":"2020","journal-title":"Clin Invest"},{"issue":"14","key":"10.1016\/j.clnesp.2021.02.017_bib149","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A\u00a0novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","year":"2016","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.clnesp.2021.02.017_bib150","doi-asserted-by":"crossref","first-page":"E507","DOI":"10.1111\/ans.15480","article-title":"Novel systemic inflammation response index to predict prognosis after thoracoscopic lung cancer surgery: a propensity score-matching study","volume":"89","author":"Li","year":"2019","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.clnesp.2021.02.017_bib151","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cam4.1428","article-title":"Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals","volume":"7","author":"Li","year":"2018","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.clnesp.2021.02.017_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144663","article-title":"Albumin and neutrophil combined prognostic grade as a new prognostic factor in non-small cell lung cancer: results from a large consecutive cohort","volume":"10","author":"Sun","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.clnesp.2021.02.017_bib153","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.21873\/anticanres.11625","article-title":"Significance of the preoperative CONUT score in predicting postoperative disease-free and overall survival in patients with lung adenocarcinoma with obstructive lung disease","volume":"37","author":"Akamine","year":"2017","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.clnesp.2021.02.017_bib154","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.21037\/jtd.2017.07.108","article-title":"Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma","volume":"9","author":"Toyokawa","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib155","doi-asserted-by":"crossref","first-page":"927","DOI":"10.21037\/jtd.2019.01.76","article-title":"A\u00a0novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase","volume":"11","author":"Takamori","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib156","doi-asserted-by":"crossref","first-page":"741","DOI":"10.21873\/anticanres.11372","article-title":"The preoperative controlling nutritional status score predicts survival after curative surgery in patients with pathological stage I non-small cell lung cancer","volume":"37","author":"Shoji","year":"2017","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.clnesp.2021.02.017_bib157","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/jir.1992.12.17","article-title":"Protein starvation impairs the ability of activated lymphocytes to produce interferon-gamma","volume":"12","author":"Mengheri","year":"1992","journal-title":"J\u00a0Interferon Res"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib158","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.clnesp.2021.02.017_bib159","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.1000021","article-title":"Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance","volume":"185","author":"Yang","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/eji.201646423","article-title":"Nutritional effects on T-cell immunometabolism","volume":"47","author":"Cohen","year":"2017","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.clnesp.2021.02.017_bib161","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance","volume":"43","author":"Soeters","year":"2019","journal-title":"JPEN - J Parenter Enter Nutr"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457721000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:04:04Z","timestamp":1762499044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457721000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":161,"alternative-id":["S2405457721000863"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.02.017","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}